Reviews synthesize that brain iron dysregulation and altered expression of iron transporters (including transferrin receptors) contribute to Alzheimer’s Disease (AD) pathology and glial dysfunction. Here, TFRC is linked to early-onset autosomal dominant Alzheimer disease.